SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney ... and Stroke

被引：0
|
作者：
Yang, Taeil [1 ]
Lee, Jooyeon [1 ]
Oh, Jaewon [1 ]
机构：
[1] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Cardiovasc Res Inst,Div Cardiol, 50-1,Yonsei Ro, Seoul 03722, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2024年 / 54卷 / 09期
关键词：
D O I：
10.4070/kcj.2024.0214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：562 / 564
页数：3
相关论文
共 50 条
  • [31] Is It Time to Relitigate SGLT2 Inhibitor Dose for Heart Failure?
    Howlett, Jonathan G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2023, 39 (05) : 662 - 664
  • [32] Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
    Lisenby, Katelin M.
    Meyer, Allison
    Slater, Nicole A.
    JOURNAL OF FAMILY PRACTICE, 2016, 65 (09): : 587 - 593
  • [33] Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes
    Jack, Gwendolyne Anyanate
    Kashyap, Sangeeta R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (10): : E1153 - E1154
  • [34] Ketoacidosis in Type 2 Diabetes with and without SGLT2 Inhibitor Therapy
    Koerbel, Theresa
    Zitterl, A.
    Jagoutz, T.
    Peric, S.
    Stulnig, T. M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S765 - S765
  • [35] SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes.
    Guthoff, M.
    Mahling, M.
    Nadalin, S.
    Heyne, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 554 - 554
  • [36] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [37] Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes
    Nigro, Stefanie C.
    Riche, Daniel M.
    Pheng, Michelle
    Baker, William L.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1301 - 1311
  • [38] Discovery of a Novel Dual SGLT1 and SGLT2 Inhibitor for Diabetes Therapy
    Xu, Yao-Chang
    Li, Chenghai
    Wang, Juanjuan
    Liao, Jianchun
    Gao, Peng
    Bao, Rudi
    Yu, Hongping
    DIABETES, 2015, 64 : A660 - A660
  • [39] Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond
    Martens P.
    Mathieu C.
    Verbrugge F.H.
    Current Treatment Options in Cardiovascular Medicine, 2017, 19 (3)
  • [40] SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
    Megan Leila Baker
    Mark Anthony Perazella
    Journal of Nephrology, 2020, 33 : 985 - 994
12345